Bioorg Med Chem Lett 2002 Jun 3;12(11):1517-20
Cutshall NS, Kucera KA, Ursino R, Latham J, Ihle NC.
Department of Chemistry, Celltech R&D Inc., 1631 220th Street SE, 98021, Bothell, WA, USA
A series of 4-fluoronicotinanilides was synthesized and shown to be novel, potent, and selective inhibitors against GRO-alpha-driven human neutrophil chemotaxis.
Compounds of this class may be useful for the treatment of inflammatory, autoimmune, and allergic disorders.